Is there a standard regimen for first-line treatment of advanced/metastatic Non-Small-Cell Lung Cancer? What has meta-analyses contributed to today's standard of care

Athanasios G. Pallis; Vassilis Georgoulias

doi:10.1016/j.lungcan.2011.09.010

Is there a standard regimen for first-line treatment of advanced/metastatic Non-Small-Cell Lung Cancer? What has meta-analyses contributed to today's standard of care

Lung Cancer ◽

10.1016/j.lungcan.2011.09.010 ◽

2012 ◽

Vol 75 (3) ◽

pp. 269-274 ◽

Cited By ~ 5

Author(s):

Athanasios G. Pallis ◽

Vassilis Georgoulias

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Standard Of Care ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Standard Regimen ◽

Meta Analyses ◽

First Line Treatment

Download Full-text

Osimertinib vs standard of care (SoC) EGFR-TKI as first-line treatment in patients with EGFR-TKI sensitising mutation (EGFRm) positive advanced non-small cell lung cancer (NSCLC): FLAURA Asian subset

Annals of Oncology ◽

10.1093/annonc/mdx729.008 ◽

2017 ◽

Vol 28 ◽

pp. x190 ◽

Cited By ~ 1

Author(s):

B.C. Cho ◽

B. Chewaskulyong ◽

K.H. Lee ◽

A. Dechaphunkul ◽

V. Sriuranpong ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Standard Of Care ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Egfr Tki ◽

First Line Treatment

Download Full-text

CN5 - COST-EFFECTIVENESS OF PEMBROLIZUMAB VERSUS STANDARD-OF-CARE CHEMOTHERAPIES FOR FIRST-LINE TREATMENT OF PD-L1 POSITIVE (≥50%) METASTATIC NON-SMALL CELL LUNG CANCER IN FRANCE

Value in Health ◽

10.1016/j.jval.2018.09.022 ◽

2018 ◽

Vol 21 ◽

pp. S4

Author(s):

C. Chouaid ◽

L. Bensimon ◽

E. Clay ◽

A. Millier ◽

L. Lévy-Bachelot ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Standard Of Care ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France

Lung Cancer ◽

10.1016/j.lungcan.2018.11.008 ◽

2019 ◽

Vol 127 ◽

pp. 44-52 ◽

Cited By ~ 17

Author(s):

Christos Chouaid ◽

Lionel Bensimon ◽

Emilie Clay ◽

Aurélie Millier ◽

Laurie Levy-Bachelot ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Standard Of Care ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Effectiveness Analysis ◽

First Line Treatment

Download Full-text

Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride

Case Medical Research ◽

10.31525/ct1-nct03890055 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Clinical Study ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC)

Case Medical Research ◽

10.31525/ct1-nct04009317 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Anaplastic Lymphoma ◽

Alk Positive ◽

First Line Treatment

Download Full-text

Phase I Study of Apatinib in Combination with Gefitinib As First-Line Treatment in Patients with EGFR-Mutant Advanced Non-Squamous Non-Small Cell Lung Cancer

SSRN Electronic Journal ◽

10.2139/ssrn.3454715 ◽

2019 ◽

Author(s):

Zhonghan Zhang ◽

Yang Zhang ◽

Fan Luo ◽

Yuxiang Ma ◽

Wenfeng Fang ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Phase I Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

Real-world outcomes for patients with metastatic non-small cell lung cancer according to first-line treatment

Revue d Épidémiologie et de Santé Publique ◽

10.1016/j.respe.2021.04.057 ◽

2021 ◽

Vol 69 ◽

pp. S36

Author(s):

Y. Belaroussi ◽

S. Cousin ◽

M. Carton ◽

M. Lebitasy ◽

L. Laborde ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Real World ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

First‐line treatment with irreversible tyrosine kinase inhibitors associated with longer OS in EGFR mutation‐positive non‐small cell lung cancer

Thoracic Cancer ◽

10.1111/1759-7714.13462 ◽

2020 ◽

Author(s):

Po‐Lan Su ◽

Chian‐Wei Chen ◽

Yi‐Lin Wu ◽

Chien‐Chung Lin ◽

Wu‐Chou Su

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

P48.09 Anlotinib Plus Etoposide and Carboplatin as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: A Single Arm Phase II Trial

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.879 ◽

2021 ◽

Vol 16 (3) ◽

pp. S503

Author(s):

B. Han ◽

W. Zhang ◽

B. Zhang ◽

Y. Chen ◽

Y. Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Extensive Stage ◽

First Line Treatment

Download Full-text

Crizotinib vs platinum‐based chemotherapy as first‐line treatment for advanced non‐small cell lung cancer with different ROS1 fusion variants

Cancer Medicine ◽

10.1002/cam4.2984 ◽

2020 ◽

Vol 9 (10) ◽

pp. 3328-3336 ◽

Cited By ~ 3

Author(s):

Haiyan Xu ◽

Quan Zhang ◽

Li Liang ◽

Junling Li ◽

Zhefeng Liu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Platinum Based Chemotherapy ◽

First Line Treatment

Download Full-text